MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
B. Oldrini, N. Vaquero-Siguero, Q. Mu…·M. Squatrito
This study shows that MGMT genomic rearrangements cause TMZ resistance in gliomas and can be detected in exosomes as potential recurrence markers.